Black Diamond Therapeutics (BDTX) Earnings (2019 - 2026)
Black Diamond Therapeutics (BDTX) earnings from Mar 31, 2019 to Mar 31, 2026. The TTM Black Diamond Therapeutics (BDTX) earnings is -$43M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Earnings
Quarterly Earnings
Black Diamond Therapeutics (BDTX) Earnings CAGR table
| Period | CAGR |
|---|---|
| 3 Years TTM | -20.66% |
| 5 Years TTM | -12.74% |
| All Time TTM | -0.13% |
Annual Earnings change of Black Diamond Therapeutics (BDTX)
| Year | Earnings | Change |
|---|---|---|
| 2026 | -$9.04M | -140.41% |
| 2025 | $22M | -132.10% |
| 2024 | -$70M | -15.48% |
| 2023 | -$82M | -9.58% |
| 2022 | -$91M | -27.41% |
| 2021 | -$126M | +86.77% |
| 2020 | -$67M | +90.73% |
| 2019 | -$35M | +294.85% |
| 2018 | -$8.93M | N/A |
Comparison Black Diamond Therapeutics (BDTX) five years earnings CAGR with competitors
Black Diamond Therapeutics (BDTX) five years earnings CAGR is -12.74%.